Drugs / Relvar
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04185129 | Jan 2020 → Dec 2021 | asthma | Far Eastern Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Relvar | “a randomized study for comparison asthma patients using Foster or Relvar. The primary end point is lung function improvement evaluation” NCT04185129 ↗ |